FDA Determines Regulatory Review Period for GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS Patent Extension

Summary

The U.S. Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS medical device, as a result of a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).